PreveCeutical Medical (TSE:PREV) has released an update.
PreveCeutical Medical Inc. has announced a delay in filing its annual financial statements due to funding shortfalls, leading to a Management Cease Trade Order (MCTO) by the British Columbia Securities Commission. The company is working to complete the filings by June 28, 2024, and in the meantime, plans to raise up to $250,000 through a private placement for working capital and audit fees. While the MCTO restricts trading for certain insiders, trading for the general public continues on the Canadian Securities Exchange.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
